Clinical impact of catheter insertion for peritoneal dialysis on patient survival and catheter-related complications.


Journal

Clinical and experimental nephrology
ISSN: 1437-7799
Titre abrégé: Clin Exp Nephrol
Pays: Japan
ID NLM: 9709923

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 17 03 2023
accepted: 09 07 2023
medline: 23 10 2023
pubmed: 27 7 2023
entrez: 27 7 2023
Statut: ppublish

Résumé

The stepwise initiation of peritoneal dialysis (PD) using Moncrief and Popovich's technique (SMAP) for catheter insertion is recommended for the systemic introduction of PD and prevention of catheter-related infections. In this study, we investigated patient outcomes in patients who underwent insertion of a PD catheter with a direct method versus the SMAP method. We enrolled 295 consecutive patients who underwent PD as a primary renal replacement therapy and underwent insertion of a PD catheter at our institute between 2006 and 2021. We retrospectively reviewed their data and investigated patient outcomes, including mortality and PD catheter-related complications. Median age at PD induction was 65 years in the direct insertion group and 65 years in the SMAP group (P = 0.80). The rate of PD introduction after emergency hemodialysis was significantly higher in the direct insertion group than in the SMAP group (P < 0.001). There was no significant difference in survival between the direct insertion and SMAP groups during the median follow-up period of 54 months (P = 0.12). Additionally, patients who transitioned to hemodialysis or kidney transplantation after PD showed significantly longer survival (P < 0.001). The incidence of PD catheter-related complications was not significantly different between the two groups. A body mass index ≥ 23 kg/m Planned sequential renal replacement therapy including hybrid hemodialysis, complete hemodialysis, and kidney transplantation after PD is important for improving patient outcomes. PD catheter insertion by SMAP may not be mandatory in our clinical practice.

Identifiants

pubmed: 37498347
doi: 10.1007/s10157-023-02382-6
pii: 10.1007/s10157-023-02382-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

941-950

Informations de copyright

© 2023. The Author(s), under exclusive licence to The Japanese Society of Nephrology.

Références

Nitta K, Goto S, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, Wada A, Hamano T, Hoshino J, Joki N, Abe M, Yamamoto K, Nakamoto H. Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality. Ren Replace Ther. 2020. https://doi.org/10.1186/s41100-020-00286-9 .
doi: 10.1186/s41100-020-00286-9
Tokgoz B. Clinical advantages of peritoneal dialysis. Perit Dial Int. 2009;29(Suppl 2):S59-61.
doi: 10.1177/089686080902902S11 pubmed: 19270233
Waldum-Grevbo B, Leivestad T, Reisæter AV, et al. Impact of initial dialysis modality on mortality: a propensity-matched study. BMC Nephrol. 2015;16:179.
doi: 10.1186/s12882-015-0175-5 pubmed: 26519164 pmcid: 4628291
Jaar BG, Plantinga LC, Crews DC, Fink NE, Hebah N, Coresh J, Kliger AS, Powe NR. Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study. BMC Nephrol. 2009;10:3.
doi: 10.1186/1471-2369-10-3 pubmed: 19200383 pmcid: 2649113
Guo A, Mujais S. Patient and technique survival on peritoneal dialysis in the United States: evaluation in large incident cohorts. Kidney Int Suppl. 2003;88:S3-12.
doi: 10.1046/j.1523-1755.2003.08801.x
Huisman RM, Nieuwenhuizen MG, Th de Charro F. Patient-related and centre-related factors influencing technique survival of peritoneal dialysis in The Netherlands. Nephrol Dial Transplant. 2002;17(9):1655–60.
doi: 10.1093/ndt/17.9.1655 pubmed: 12198219
Moncrief JW, Popovich RP, Dasgupta M, Costerton JW, Simmons E, Moncrief B. Reduction in peritonitis incidence in continuous ambulatory peritoneal dialysis with a new catheter and implantation technique. Perit Dial Int. 1993;13(Suppl 2):S329–31.
doi: 10.1177/089686089301302S81 pubmed: 8399601
Guidelines for peritoneal dialysis. The Japanese society for dialysis therapy. 2019. https://minds.jcqhc.or.jp/docs/gl_pdf/G0001152/4/peritoneal_dialysis.pdf . Accessed 4 Feb 2023.
Tang SC, Ho YW, Tang AW, Cheng YY, Chiu FH, Lo WK, Lai KN, Hong Kong Peritoneal Dialysis Study Group. Delaying initiation of dialysis till symptomatic uraemia—is it too late? Nephrol Dial Transplant. 2007;22(7):1926–32.
doi: 10.1093/ndt/gfm109 pubmed: 17400562
Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuijper EJ, Lye WC, Salzer W, Schaefer F, Struijk DG, International Society for Peritoneal Dialysis. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int. 2010;30(4):393–423.
doi: 10.3747/pdi.2010.00049 pubmed: 20628102
McDonald SP, Collins JF, Rumpsfeld M, Johnson DW. Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int. 2004;24(4):340–6.
doi: 10.1177/089686080402400408 pubmed: 15335147
Obi Y, Streja E, Mehrotra R, Rivara MB, Rhee CM, Soohoo M, Gillen DL, Lau WL, Kovesdy CP, Kalantar-Zadeh K. Impact of obesity on modality longevity, residual kidney function, peritonitis, and survival among incident peritoneal dialysis patients. Am J Kidney Dis. 2018;71(6):802–13.
doi: 10.1053/j.ajkd.2017.09.010 pubmed: 29223620
Sato T, Anan G, Hirose T, Tajima R, Hoshino K, Miyake Y, Fukunaga T, Kato T, Endo A, Ito H, Nakayama S, Hashimoto H, Ishiyama K, Kimura T, Mori T. The impact of preoperative risk factors on peritoneal dialysis-related peritonitis: a single-center prospective study in Japan. Medicina (Kaunas). 2022;58(2):313.
doi: 10.3390/medicina58020313 pubmed: 35208636
Nessim SJ, Komenda P, Rigatto C, Verrelli M, Sood MM. Frequency and microbiology of peritonitis and exit-site infection among obese peritoneal dialysis patients. Perit Dial Int. 2013;33(2):167–74.
doi: 10.3747/pdi.2011.00244 pubmed: 22942268 pmcid: 3598106
Hama EY, Uchiyama K, Nagasaka T, Kusahana E, Nakayama T, Yasuda I, Morimoto K, Washida N, Itoh H. High body mass index is a risk factor for transition to hemodialysis or hybrid therapy and peritoneal dialysis-related infection in Japanese patients undergoing peritoneal dialysis. Int Urol Nephrol. 2022;54(12):3193–202.
doi: 10.1007/s11255-022-03252-y pubmed: 35759207
van Laanen JHH, Cornelis T, Mees BM, Litjens EJ, van Loon MM, Tordoir JHM, Peppelenbosch AG. Randomized controlled trial comparing open versus laparoscopic placement of a peritoneal dialysis catheter and outcomes: the CAPD I trial. Perit Dial Int. 2018;38(2):104–12.
doi: 10.3747/pdi.2017.00023 pubmed: 29386303
Sun ML, Zhang Y, Wang B, Ma TA, Jiang H, Hu SL, Zhang P, Tuo YH. Randomized controlled trials for comparison of laparoscopic versus conventional open catheter placement in peritoneal dialysis patients: a meta-analysis. BMC Nephrol. 2020;21(1):60.
doi: 10.1186/s12882-020-01724-w pubmed: 32093633 pmcid: 7038608
Jwo SC, Chen KS, Lee CC, Chen HY. Prospective randomized study for comparison of open surgery with laparoscopic-assisted placement of Tenckhoff peritoneal dialysis catheter—a single center experience and literature review. J Surg Res. 2010;159(1):489–96.
doi: 10.1016/j.jss.2008.09.008 pubmed: 19482306
Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med. 2011;171(2):110–8.
doi: 10.1001/archinternmed.2010.352 pubmed: 20876398
Perl J, Wald R, Bargman JM, Na Y, Jassal SV, Jain AK, Moist L, Nessim SJ. Changes in patient and technique survival over time among incident peritoneal dialysis patients in Canada. Clin J Am Soc Nephrol. 2012;7(7):1145–54.
doi: 10.2215/CJN.01480212 pubmed: 22554718 pmcid: 3386671
Lee SW, Lee NR, Son SK, Kim J, Sul AR, Kim Y, Park JT, Lee JP, Ryu DR. Comparative study of peritoneal dialysis versus hemodialysis on the clinical outcomes in Korea: a population-based approach. Sci Rep. 2019;9(1):5905.
doi: 10.1038/s41598-019-42508-z pubmed: 30976069 pmcid: 6459886
Chang YK, Hsu CC, Hwang SJ, Chen PC, Huang CC, Li TC, Sung FC. A comparative assessment of survival between propensity score-matched patients with peritoneal dialysis and hemodialysis in Taiwan. Medicine (Baltimore). 2012;91(3):144–51.
doi: 10.1097/MD.0b013e318256538e pubmed: 22525667

Auteurs

Shunta Hori (S)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Mitsuru Tomizawa (M)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Kuniaki Inoue (K)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Tatsuo Yoneda (T)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Akira Tachibana (A)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Kenta Onishi (K)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Yosuke Morizawa (Y)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Daisuke Gotoh (D)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Yasushi Nakai (Y)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Makito Miyake (M)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Kazumasa Torimoto (K)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Nobumichi Tanaka (N)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.
Department of Prostate Brachytherapy, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.

Kiyohide Fujimoto (K)

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan. kiyokun@naramed-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH